Armstrong Pharmaceuticals Inc
General
Total Cases1
Active Cases--
Patents--
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 02/11/25 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # [1] Dismissal)(mdb) (Entered: 02/11/2025) | |
| 02/11/25 | SO ORDERED re [25] CONSENT ORDER OF DISMISSAL ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 2/11/2025. (dlw) (Entered: 02/11/2025) | |
| 02/10/25 | Consent Order of Dismissal by Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd., Teva Pharmaceuticals USA, Inc. (Keller, Karen) Modified on 2/11/2025 (dlw). (Entered: 02/10/2025) | |
| 02/10/25 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Norton (Waterford) Ltd., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc. filed by Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) (Entered: 02/10/2025) | |
| 02/10/25 | NOTICE of Change of Name and Request to Update Party's Name on Docket by Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd., Teva Pharmaceuticals USA, Inc. (Keller, Karen) (Entered: 02/10/2025) | |
| 01/10/25 | STIPULATION TO EXTEND TIME to Submit an Application to the Court for a Protective Order and to Exchange Rule 26(a) Initial Disclosures to February 6, 2025 - filed by Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) (Entered: 01/10/2025) | |
| 01/10/25 | SO ORDERED re [22] STIPULATION TO EXTEND TIME to Submit an Application to the Court for a Protective Order and to Exchange Rule 26(a) Initial Disclosures to February 6, 2025. ORDERED by Judge Maryellen Noreika on 1/10/2025. (dlw) (Entered: 01/10/2025) | |
| 01/08/25 | NOTICE OF SERVICE of Plaintiffs' Identification of Accused Products, Asserted Patents and File Histories, and Damages Model filed by Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd., Teva Pharmaceuticals USA, Inc..(Keller, Karen) (Entered: 01/08/2025) | |
| 12/18/24 | SCHEDULING ORDER: Joinder of Parties due by 2/3/2025. Amended Pleadings due by 2/3/2025. Fact Discovery completed by 9/12/2025. Opening Expert Reports due by 4/24/2026. Rebuttal Expert Reports due by 6/19/2026. Reply Expert Reports due by 7/17/2026. Expert Discovery due by 9/10/2026. Dispositive Motions due by 9/25/2026. Answering Brief due 10/29/2026. Reply Brief due 11/12/2026. Claim Construction Opening Brief served by 10/24/2025. Claim Construction Answering Brief served by 11/21/2025. Claim Construction Reply Brief served by 12/23/2025. Claim Construction Surreply Brief served by 1/9/2026. Joint Claim Construction Brief filed by 1/20/2026. A Markman Hearing is set for 2/20/2026 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 3/1/2027 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Jury Trial is set for 3/8/2027 at 09:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 12/18/2024. (dlw) (Entered: 12/18/2024) | |
| 12/16/24 | Pro Hac Vice Fee - Credit Card Payment received for Daryl L. Wiesen, Louis L. Lobel, Thomas V. McTigue IV, and Annaka Nava. ( re [18] MOTION for Pro Hac Vice Appearance of Attorney Daryl L. Wiesen, Louis L. Lobel, Thomas V. McTigue IV and Annaka Nava )( Payment of $ 200, receipt number ADEDC-4571246).(Hoeschen, Nathan) (Entered: 12/16/2024) |